Template:CMV neurologic disease treatment: Difference between revisions
Ostermayer (talk | contribs) (Created page with "*Ganciclovir 5mg/kg IV q12hrs daily x 21 days FOLLOWED BY 5mg/kg IV q24hrs + **Foscarnet 90mg/kg IV q12hrs x 21 days THEN 90-120mg/kg IV q24hrs") |
(Strip translate tags to enable SMW subobject creation) |
||
| (5 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
*Ganciclovir 5mg/kg IV q12hrs | *{{AntibioticDose|disease=CMV neurologic disease|drug=Ganciclovir|dose=5mg/kg IV q12hrs x 21 days then 5mg/kg IV q24hrs|context=Combined with Foscarnet|population=Adult}} + | ||
**Foscarnet 90mg/kg IV q12hrs x 21 days | **{{AntibioticDose|disease=CMV neurologic disease|drug=Foscarnet|dose=90mg/kg IV q12hrs x 21 days then 90-120mg/kg IV q24hrs|context=Combined with Ganciclovir|population=Adult}} | ||
Latest revision as of 02:54, 20 March 2026
- Ganciclovir 5mg/kg IV q12hrs x 21 days then 5mg/kg IV q24hrs +
- Foscarnet 90mg/kg IV q12hrs x 21 days then 90-120mg/kg IV q24hrs
